239 related articles for article (PubMed ID: 18924211)
21. Subtoxic concentrations of allergenic haptens induce LC migration and maturation in a human organotypic skin explant culture model: a novel method for identifying potential contact allergens.
Lehé CL; Jacobs JJ; Hua CM; Courtellemont P; Elliott GR; Das PK
Exp Dermatol; 2006 Jun; 15(6):421-31. PubMed ID: 16689858
[TBL] [Abstract][Full Text] [Related]
22. Regulation of CXCL12 and CXCR4 expression by human brain endothelial cells and their role in CD4+ and CD8+ T cell adhesion and transendothelial migration.
Liu KK; Dorovini-Zis K
J Neuroimmunol; 2009 Oct; 215(1-2):49-64. PubMed ID: 19765831
[TBL] [Abstract][Full Text] [Related]
23. Inter-laboratory study of the in vitro dendritic cell migration assay for identification of contact allergens.
Rees B; Spiekstra SW; Carfi M; Ouwehand K; Williams CA; Corsini E; McLeod JD; Gibbs S
Toxicol In Vitro; 2011 Dec; 25(8):2124-34. PubMed ID: 22001958
[TBL] [Abstract][Full Text] [Related]
24. Cytokines and Langerhans cell mobilisation in mouse and man.
Griffiths CE; Dearman RJ; Cumberbatch M; Kimber I
Cytokine; 2005 Oct; 32(2):67-70. PubMed ID: 16153855
[TBL] [Abstract][Full Text] [Related]
25. Reconstructed human epidermis: absence of Langerhans cells and failure to stimulate allogeneic lymphocytes in vitro.
Bagot M; Bertaux B; Heslan M; Coulomb B; Dubertret L
Clin Exp Immunol; 1988 Jan; 71(1):138-43. PubMed ID: 2964953
[TBL] [Abstract][Full Text] [Related]
26. Arsenic mobilizes Langerhans cell migration and induces Th1 response in epicutaneous protein sensitization via CCL21: a plausible cause of decreased Langerhans cells in arsenic-induced intraepithelial carcinoma.
Lee CH; Hong CH; Yu CL; Wang LF; Clausen BE; Liao WT; Huang SK; Chen GS; Yu HS
Biochem Pharmacol; 2012 May; 83(9):1290-9. PubMed ID: 22321510
[TBL] [Abstract][Full Text] [Related]
27. The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL-4/IL-13 signaling.
Dupasquier M; Stoitzner P; Wan H; Cerqueira D; van Oudenaren A; Voerman JS; Denda-Nagai K; Irimura T; Raes G; Romani N; Leenen PJ
J Leukoc Biol; 2006 Oct; 80(4):838-49. PubMed ID: 16849611
[TBL] [Abstract][Full Text] [Related]
28. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
[TBL] [Abstract][Full Text] [Related]
29. Development of motility of Langerhans cell through extracellular matrix by in vitro hapten contact.
Kobayashi Y; Staquet MJ; Dezutter-Dambuyant C; Schmitt D
Eur J Immunol; 1994 Sep; 24(9):2254-7. PubMed ID: 8088339
[TBL] [Abstract][Full Text] [Related]
30. Characterization of reconstructed human skin containing Langerhans cells to monitor molecular events in skin sensitization.
Bock S; Said A; Müller G; Schäfer-Korting M; Zoschke C; Weindl G
Toxicol In Vitro; 2018 Feb; 46():77-85. PubMed ID: 28941582
[TBL] [Abstract][Full Text] [Related]
31. Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis.
Bennaceur K; Popa I; Portoukalian J; Berthier-Vergnes O; Péguet-Navarro J
Int Immunol; 2006 Jun; 18(6):879-86. PubMed ID: 16675488
[TBL] [Abstract][Full Text] [Related]
32. A model system using tape stripping for characterization of Langerhans cell-precursors in vivo.
Holzmann S; Tripp CH; Schmuth M; Janke K; Koch F; Saeland S; Stoitzner P; Romani N
J Invest Dermatol; 2004 May; 122(5):1165-74. PubMed ID: 15140219
[TBL] [Abstract][Full Text] [Related]
33. Titanium salts tested in reconstructed human skin with integrated MUTZ-3-derived Langerhans cells show an irritant rather than a sensitizing potential.
Rodrigues Neves CT; Spiekstra SW; de Graaf NPJ; Rustemeyer T; Feilzer AJ; Kleverlaan CJ; Gibbs S
Contact Dermatitis; 2020 Nov; 83(5):337-346. PubMed ID: 32677096
[TBL] [Abstract][Full Text] [Related]
34. Participation of epidermal langerhans cells in human pathology and their potential as targets for drug development: a review of literature.
Ayala-García I; Hernández-Segura AM; Castell-Rodríguez A; Alvarez Pérez SJ; Téllez BH; Ramírez-González MD
Proc West Pharmacol Soc; 2005; 48():13-20. PubMed ID: 16416652
[TBL] [Abstract][Full Text] [Related]
35. Differential migration of epidermal and dermal dendritic cells during skin infection.
Eidsmo L; Allan R; Caminschi I; van Rooijen N; Heath WR; Carbone FR
J Immunol; 2009 Mar; 182(5):3165-72. PubMed ID: 19234214
[TBL] [Abstract][Full Text] [Related]
36. Migration and maturation of Langerhans cells in skin transplants and explants.
Larsen CP; Steinman RM; Witmer-Pack M; Hankins DF; Morris PJ; Austyn JM
J Exp Med; 1990 Nov; 172(5):1483-93. PubMed ID: 2230654
[TBL] [Abstract][Full Text] [Related]
37. Chemokine CXCL12 promotes the cross-talk between trophoblasts and decidual stromal cells in human first-trimester pregnancy.
Zhou WH; Du MR; Dong L; Yu J; Li DJ
Hum Reprod; 2008 Dec; 23(12):2669-79. PubMed ID: 18687671
[TBL] [Abstract][Full Text] [Related]
38. Comparison of a novel CXCL12/CCL5 dependent migration assay with CXCL8 secretion and CD86 expression for distinguishing sensitizers from non-sensitizers using MUTZ-3 Langerhans cells.
Ouwehand K; Spiekstra SW; Reinders J; Scheper RJ; de Gruijl TD; Gibbs S
Toxicol In Vitro; 2010 Mar; 24(2):578-85. PubMed ID: 19878716
[TBL] [Abstract][Full Text] [Related]
39. Densities, distribution and phenotypic expression of T cells in human fetal skin.
Di Nuzzo S; Pavanello P; Masotti A; Giordano G; De Panfilis G
Arch Dermatol Res; 2009 Oct; 301(10):753-5. PubMed ID: 19308434
[TBL] [Abstract][Full Text] [Related]
40. Assessment of contact allergens by dissociation of irritant and sensitizing properties.
Jacobs JJ; Lehé CL; Cammans KD; Das PK; Elliott GR
Toxicol In Vitro; 2004 Oct; 18(5):681-90. PubMed ID: 15251187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
